Francesco Ferrara | Pharmacist | Innovative Research Award

Published on by Research Awards

Innovative Research Award

Francesco Ferrara – ASL Napoli 3 SUD, Italy
Francesco Ferrara
AffiliationASL Napoli 3 SUD
CountryItaly
Scopus ID59464334600
Documents1546
Citations2176
h-index27
Subject AreaPharmacist
EventInternational Research Awards
ORCID0000-0001-9298-6783

Francesco Ferrara is an Italian hospital pharmacist and researcher affiliated with ASL Napoli 3 SUD. His academic profile demonstrates extensive contributions to pharmacology, clinical pharmacy, healthcare governance, and therapeutic innovation. Through a substantial publication record and active international collaboration, he has contributed to evidence-based healthcare practices and multidisciplinary medical research.[1]

Abstract

This article evaluates the scholarly profile of Francesco Ferrara in relation to the Innovative Research Award. His research activities encompass pharmacology, healthcare management, antimicrobial resistance, chronic disease treatment, and pharmaceutical policy. The combination of publication productivity, citation influence, and interdisciplinary engagement highlights a sustained commitment to advancing healthcare knowledge and clinical practice.[1]

Keywords

Pharmacology, Clinical Pharmacy, Healthcare Governance, Drug Policy, Therapeutic Innovation, Antimicrobial Resistance, Pharmaceutical Research.

Introduction

Modern healthcare requires researchers capable of integrating clinical evidence, pharmaceutical management, and public health priorities. Francesco Ferrara has developed a multidisciplinary portfolio addressing therapeutic effectiveness, healthcare sustainability, and emerging treatment strategies. His work reflects contemporary priorities in patient-centered care and pharmaceutical innovation.[2]

Research Profile

Ferrara serves within the Italian Health Service and has accumulated professional experience across multiple healthcare institutions. His expertise includes clinical pharmacy, pharmacoeconomics, healthcare technology assessment, and pharmaceutical governance. The researcher maintains active participation in scientific publishing and peer-review activities across internationally recognized journals.[1]

Research Contributions

Key contributions include investigations into antimicrobial resistance, biosimilar medicines, chronic disease management, neurological disorders, dermatological therapies, and healthcare expenditure analysis. His research frequently combines clinical relevance with policy implications, supporting informed decision-making in healthcare systems and pharmaceutical practice.[3]

Publications

Publications

Francesco Ferrara has authored and co-authored an extensive portfolio of scholarly publications spanning pharmacology, clinical pharmacy, antimicrobial resistance, chronic disease management, dermatology, neurology, cardiovascular medicine, and healthcare governance. His research has appeared in internationally recognized journals including Inflammopharmacology, European Journal of Clinical Pharmacology, Pharmaceuticals, Antibodies, and Hospital Pharmacy. Through collaborations with multidisciplinary research teams, he has contributed to studies addressing therapeutic innovation, drug utilization, public health challenges, and evidence-based healthcare policies. The breadth and consistency of his publication record demonstrate sustained scientific productivity and a commitment to advancing pharmaceutical and clinical research across diverse healthcare settings.[2][3]

Research Impact

With more than two thousand citations and a substantial h-index, Ferrara’s scholarly output demonstrates measurable academic influence. His studies contribute to clinical practice, healthcare policy development, and pharmaceutical governance. The broad thematic coverage of his work illustrates a capacity to address both specialized and system-level healthcare challenges.[1]

Award Suitability

The Innovative Research Award recognizes individuals who demonstrate originality, sustained scholarly productivity, and meaningful research outcomes. Ferrara’s record of publications, international collaborations, and healthcare-focused investigations aligns with these criteria. His contributions support innovation in pharmacological science and evidence-based healthcare management.[4]

Conclusion

Francesco Ferrara has established a notable academic profile through sustained research activity, clinical expertise, and interdisciplinary collaboration. His contributions to pharmacology and healthcare policy provide practical and scholarly value. These achievements support his recognition as a strong candidate for the Innovative Research Award.[5]

References

    1. ORCID. (2026). Francesco Ferrara (ORCID iD: 0000-0001-9298-6783). ORCID Registry.
      https://orcid.org/0000-0001-9298-6783
    2. Ferrara, F., De Berardinis, F., Scognamiglio, M., & Zovi, A. (2026). The shifting paradigm of monoclonal antibodies in COVID-19 management: From early triumphs to viral resistance and future perspectives. Antibodies, 15(3), Article 48.
      https://doi.org/10.3390/antib15030048
    3. Ferrara, F. (2026). Therapeutic update on alopecia areata: A critical review of standard and emerging targeted therapies. Inflammopharmacology.
      https://doi.org/10.1007/s10787-026-02273-8
    4. Ferrara, F., Martellone, L., Vaccaro, M., Coluccia, A., Scognamiglio, M., Langella, R., Zovi, A., & Polito, G. (2025). Real-life impact of cefiderocol in carbapenem-resistant Acinetobacter baumannii infections (CRAb): A narrative review. European Journal of Clinical Pharmacology.
      https://doi.org/10.1007/s00228-025-03866-y
    5. Elsevier. (2026). Scopus Author Profile: Francesco Ferrara (Author ID: 59464334600). Scopus Preview.
      https://www.scopus.com/authid/detail.uri?authorId=59464334600

Touhidul Islam Tanim | Pharmacy | Young Scientist Award | 13317

Published on by Research Awards

Mr. Touhidul Islam Tanim | Pharmacy | Young Scientist Award

Mr. Touhidul Islam Tanim, Gopalgonj Science and Technology University, Bangladesh

Mr. Touhidul Islam Tanim is a dedicated researcher from Gopalganj Science and Technology University, Bangladesh, with expertise in pharmaceutical sciences. His research focuses on drug discovery, molecular docking, and pharmacological studies. He has co-authored multiple peer-reviewed publications in reputable journals, including Journal of Functional Foods and Khulna University Studies. As a Research Assistant at BioLuster Research Center Ltd., he conducts in-vivo experiments and contributes to scholarly writing. His work has earned him several accolades, including recognition in bioinformatics and computational biology. With a strong academic background and industry training, he is committed to advancing medical science for human health improvement.

Profile

Google Scholar

Early Academic Pursuits 🎓

Mr. Touhidul Islam Tanim began his academic journey with a strong foundation in science, showcasing excellence from an early stage. He completed his Secondary School Certificate (SSC) in 2015 from Barishal Zilla School with an outstanding GPA of 5.00 out of 5.00. His academic brilliance continued through his Higher Secondary Certificate (HSC) in 2017 at Govt. Syed Hatem Ali College, achieving the same remarkable GPA.

With a passion for pharmaceutical sciences and medical research, he pursued a Bachelor of Pharmacy (B. Pharm) at Gopalganj Science and Technology University (2018-2022), securing a CGPA of 3.49 out of 4.00. Currently, he is pursuing his Master of Pharmacy (M. Pharm, Thesis) at the same institution (2023-2025), with an impressive CGPA of 3.76 out of 4.00. His academic excellence is further highlighted by his IELTS score of 7, indicating strong proficiency in English, which aids in his global research collaborations.

Professional Endeavors 🔬

With a deep passion for drug discovery, molecular docking, and pharmacological studies, Mr. Tanim embarked on his professional journey as a Research Assistant (RA) at BioLuster Research Center Ltd. in 2024. His responsibilities include:

  • Conducting in-vivo and in-silico pharmacological experiments
  • Performing extensive literature reviews
  • Writing research and review articles for international publications
  • Exploring bioinformatics applications in drug research

Additionally, he underwent industrial training at General Pharmaceuticals Ltd., where he gained hands-on experience in quality control, assurance, microbiology, product development, and regulatory compliance.

Contributions and Research Focus 🧪

Mr. Tanim’s research is dedicated to human disease treatment, with a focus on natural compounds, pharmacodynamics, and drug interactions. His key research contributions include:

Published Research Works 📖

  1. Antiemetic activity of Sesamol – Explores the serotonergic and dopaminergic pathways in Journal of Functional Foods
  2. Clot lysis and membrane protection potentials of Cheilanthes tenuifolia methanolic leaf extract – Published in Khulna University Studies
  3. 6-Shogaol: A Short Review – Published in Clinical Research Notes
  4. Sesamol’s anti-inflammatory and synergistic properties with Celecoxib and Ketoprofen (DOI: https://doi.org/10.1016/j.ctmp.2025.200203)

Manuscripts Under Review 📑

  • Sesamol’s Antidiarrheal Potential in Castor Oil-Induced Diarrheal Models
  • Anxiolytic Effects of Citral in Swiss Albino Mice through the GABAergic interaction pathway
  • Quercetin’s Role in Modulating d-pinitol-mediated Anxiolytic-like Effects

His extensive research work combines in-vivo, in-silico, and molecular docking methodologies, contributing significantly to pharmacology, computational biology, and drug discovery.

Accolades and Recognition 🏆

Mr. Tanim’s dedication to research has earned him several prestigious awards and achievements, including:

  • Finalist Certificate from the 1st Biology and Bioinformatics Olympiad organized by BioPC
  • Certificate from Online Workshop on Article Writing & Computational Studies by BioLuster Research Center Ltd.
  • Membership Certificate from GSTU Research and Higher Studies Society

His publications, ongoing research, and professional contributions are widely recognized in the pharmaceutical and medical research communities.

Impact and Influence 🌍

As an emerging researcher, Mr. Tanim’s work is reshaping pharmaceutical sciences, particularly in:

  • Vector Control – His studies on sesamol’s anti-inflammatory and antiemetic properties have potential applications in treating gastrointestinal disorders.
  • Collaborative Efforts – His partnerships with international researchers, industry experts, and academic institutions enhance knowledge exchange.
  • Applied Research – His focus on natural bioactive compounds contributes to drug development and disease management.
  • Geographic Impact – His research spans Bangladesh, the Middle East, and Western academia, making his work globally relevant.

His efforts in bioinformatics, molecular docking, and pharmacology position him as a promising innovator in medical science.

Legacy and Future Contributions 🚀

Looking ahead, Mr. Tanim aims to:

  • Develop novel drug formulations based on plant-based bioactive compounds
  • Enhance collaborations with global research institutions and pharmaceutical industries
  • Bridge the gap between computational biology and pharmacology for effective drug screening
  • Inspire young researchers through mentorship, training, and scholarly contributions

His dedication, expertise, and research impact position him as a future leader in pharmaceutical innovation.